Akero Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Akero Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Akero Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.47M, a 30.1% increase year-over-year.
  • Akero Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $28.6M, a 47.5% increase year-over-year.
  • Akero Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $21.5M, a 7.51% decline from 2022.
  • Akero Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $23.2M, a 131% increase from 2021.
  • Akero Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.1M, a 67% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21.5M -$1.75M -7.51% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $23.2M +$13.2M +131% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $10.1M +$4.03M +67% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $6.02M +$4.25M +240% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 $1.77M +$1.65M +1363% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $121K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.